Year
Edition number
№8 / 2021
ORIGINAL STUDIES
Ladnov D.V., Kulik V.V., Kirpichnikov S.I., Shaporova N.L.
Mild forms of COVID-19: the clinical course features in patients with chronic obstructive pulmonary disease7-13
Antonov V.N., Osikov M.V., Ignatova G.L., Zotov S.O.
Heparin type influence on cellular hemostasis indicators in COVID-19-associated pneumonia14-21
Baranov D.Z., Trofimov V.I., Lapin S.V., Mazing A.V., Kholopova I.V., Kuznetsova D.A., Moshnikova A.N., Blinova T.V.
Evaluation of periostin in case of bronchoostructive diseases22-29
Sorokina L.N., Pavlova A.S., Mineev V.N., Trofimov V.I.
Chronic obstructive pulmonary disease in combination with type 2 diabetes mellitus: features of the clinical picture30-37
Ignatova I.V., Blinova E.V., Antonov V.N.
Analysis of factors of poor outcome in patients with COPD and type 2 diabetes mellitus: results of a 10-year follow-up38-45
Shuginova T.N., Meldo A.A., Shaporova N.L., Moiseenko F.V., Klikunova K.A.
Pulmonary function test for chronic obstructive pulmonary disease patients with non-small cell lung cancer46-53
Vysotskaya N.V., Li V.V., Zadionchenko V.S., Adasheva T.V., Dolbin S.S., Timofeeva N.Yu.
Vascular wall rigidity in chronic obstructive pulmonary disease patients54-64
Kucherenko N.G., Bebekh A.N., Umarova I.A., Gorelov A.I.
Dyspnoea and respiratory mechanics disturbances in obesity patients65-69
Kobzeva N.D.
Features of the influence of atherosclerotic damage of various vascular basins on the risk of development of fatal and non-fatal events in a long period70-75
Umetov M.A., Khakuasheva I.A., Akkaeva M.R., Tamazova M.A., Sanova A.Z., Khakulova D.M.
Influence of complex drug therapy on structural and functional properties of vessels and endothelial dysfunction in patients with arterial hypertension and ischemic heart disease76-83
Heylo T.S., Danilogorskaya Yu.A., Nazarenko G.B., Gladysheva E.G.
Dynamics of microcirculation indices in patients with chronic ischemic diseases of the central nervous and cardiovascular systems84-92
Shchemeleva E.V., Skorodumova E.A.
Adherence to therapy in patients with gout93-101
REVIEWS
Nevzorova V.A., Bondareva Zh.V., Potapova E.S., Egorova D.V.
Issues of immunoprophylaxis in the practice of a general practitio102-114
Vertkin A.L., Shamuilova M.M., Knorring G.Yu.
Herbal medicinal products in treatment of respiratory infections115-120
Alieva A.M., Pinchuk T.V., Batov M.A., Voronkova K.V., Valiev R.K., Shnakhova L.M., Kalova M.R., Rakhaev A.M., Arakelyan R.A., Nikitin I.G.
Sindecan-1 and cardiovascular diseases121-128
GUIDELINES FOR PRACTITIONERS
Larina V.N., Karpenko D.G.
Possibilities of combined antiplatelet and anticoagulant therapy in older patients without atrial fibrillation129-137
Druk I.V., Pomorgailo E.G., Martirosyan K.A., Petrosyan V.Yu., Trofimova N.N.
Tumor of the genital cord138-142
LECTURE
Babak S.L., Budnevsky A.V., Buzunov R.V.
Modern strategy of diagnosis and therapy of patients with obstructive sleep apnea144-150
ACTUAL ISSUES OF PHARMACOTHERAPY
Lyamina N.P.
Modern strategy of anti-ischemic therapy for patients with chronic coronary syndromes151-157
Shishkova V.N., Kotova M.B., Kapustina L.A., Imamgayazova K.E.
Issues of pathogenesis of cognitive and psychoemotional disorders in patients with cardiovascular and metabolic diseases158-163
Katunina E.A.
Limbic-predominant age-related TDP-43 encephalopathy: new nosological form of dementia164-171
Frolova Yu.V., Golanova N.M., Listradenkova D.G., Amon E.P., Malinnikova E.Yu.
Results of observational post-registration study of the efficacy and safety of Trekrezan® medicine use in adult patients with acute respiratory viral infection172-181
Activities of RNMOT
Digest events in OCTOBER 2021
182-186
WE REMEMBER
Borodulin V.I., Stochik A.A.
On the problem of institutionalization of therapeutic disciplines: Academician of the USSR Academy of Medical Sciences A.I. Nesterov as the founder of Soviet rheumatology187-192
